RPTX - Repare Therapeutics Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts6577
Avg. Estimate-0.77-0.67-2.72-3.32
Low estimate-0.92-0.95-3.67-4.07
High estimate-0.56-0.42-2.26-2.9
Year ago EPS-0.911.71-0.69-2.72
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5567
Avg. Estimate8.22M12.22M43.68M24.98M
Low estimateN/AN/A5.7M10M
High estimate17M25M66M50M
Year ago sales679k112.55M131.83M43.68M
Sales growth (year/est)1,110.60%-89.10%-66.90%-42.80%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.85-0.89-0.72-0.81
Actual EPS-0.911.71-0.75-0.83
Difference-0.062.6-0.03-0.02
Surprise %-7.10%292.10%-4.20%-2.50%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.77-0.67-2.72-3.32
7 days ago-0.77-0.67-2.72-3.32
30 days ago-0.75-0.84-2.69-3.23
60 days ago-0.75-0.84-2.77-3.43
90 days ago-0.77-0.87-3.01-3.17
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2325
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRPTXIndustrySector(s)S&P 500
Current qtr.15.40%N/AN/AN/A
Next qtr.-139.20%N/AN/AN/A
Current year-294.20%N/AN/AN/A
Next year-22.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A